Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model

Current treatments for demyelinating diseases are generally only capable of ameliorating the symptoms, with little to no effect in decreasing myelin loss nor promoting functional recovery. Mesenchymal stem cells (MSCs) have been shown by many researchers to be a potential therapeutic tool in treatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz-Martinez, P, González-Granero, S, Molina-Navarro, M M, Pacheco-Torres, J, García-Verdugo, J M, Geijo-Barrientos, E, Jones, J, Martinez, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917663/
https://www.ncbi.nlm.nih.gov/pubmed/27171265
http://dx.doi.org/10.1038/cddis.2016.130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917663/
https://www.ncbi.nlm.nih.gov/pubmed/27171265
http://dx.doi.org/10.1038/cddis.2016.130

Ejemplares similares